Synthesis, anticancer activity and mitochondrial mediated apoptosis inducing ability of 2,5-diaryloxadiazole-pyrrolobenzodiazepine conjugates

New class of 2,5-diaryloxadiazole-pyrrolobenzodiazepine conjugates have been prepared and evaluated for their anticancer activity. Further, some of the biological assays related to mechanism aspects have also been carried out.